Challenging the Low FODMAP Diet in SIBO Treatment: Is There a Place for Prebiotic Fiber?

Small intestinal bacterial overgrowth (SIBO) is a condition characterized by excessive gas formation due to bacterial fermentation of carbohydrate substrates, including prebiotic fiber. Naturally, patients tend to avoid high fiber diets, which reduces gas, bloating, and other troublesome symptoms. One of the treatments used for SIBO in clinical practice is a low FODMAP (Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols) diet, which eliminates fermentable carbohydrate substrates, resulting in symptom relief. However, a low fiber, low FODMAP diet has negative consequences for overall microbiome health. In this article, we will explore an unconventional approach to incorporating prebiotics into SIBO treatment.

Current SIBO Treatment Approach

SIBO is a common gastrointestinal condition affecting 2.5 to 22% of the population.¹ Recurrence occurs in up to 43% of patients even after successful treatment.² An antimicrobial approach, using antibiotics and/or herbal protocols, is commonly used to address SIBO. Additionally, clinicians may also recommend a low FODMAP diet (LFD) to “starve” the bacteria and reduce symptoms. The LFD may be recommended during treatment and/or as a preventative strategy following treatment.

As a medical education specialist at a functional medicine lab offering SIBO and stool testing, I’ve reviewed hundreds of clinicians’ SIBO cases. Patients with confirmed or suspected SIBO commonly show dysbiosis on stool testing, including altered beneficial short-chain fatty acids (SCFAs) like butyrate, which support gut integrity and reduce inflammation. This creates a clinical dilemma: therapies that support the microbiome and SCFA balance, such as fiber, prebiotics, and probiotics, may worsen SIBO symptoms, while antimicrobials and LFDs can further drive dysbiosis.

Many clinicians overcome this dilemma by addressing SIBO in phases—by eradicating the overgrowth first, then restoring healthy digestive physiology later. The initial treatment phase may involve antimicrobials and an LFD, followed by a reintroduction of certain FODMAP foods, prebiotics, probiotics, digestive support, motility agents, and other therapies.³

There is a challenging viewpoint to this, which includes prebiotic administration instead of the LFD. I first came across this idea a few years ago while reading a blog post by a gastroenterologist based in Spain. It may seem counterintuitive to “feed” the bacteria with prebiotics, but there is some evidence that they may be a beneficial alternative.

Probiotics during SIBO treatment are also controversial; however, they are not the focus of this article.

The Low FODMAP Diet (LFD)

FODMAP foods are short-chain carbohydrates that are slowly absorbed or indigestible in the small intestine. They can be fermented by the microbiota. Fermentation produces gases leading to abdominal distension and discomfort, gas, bloating, and diarrhea, symptoms commonly associated with irritable bowel syndrome (IBS), SIBO, and other gastrointestinal (GI) conditions. Elimination of these foods often leads to symptom improvement.

The LFD has been adopted internationally as a front-line therapy for IBS.⁴ There are many variations of the LFD, each designed by various SIBO experts and institutions, and they all share a form of carbohydrate restriction.⁵  A quick online search yields several lists comparing high and low-FODMAP foods.

The use of the LFD for SIBO is extrapolated from the data on its use for IBS. Well-designed clinical trials specifically on LFD success in SIBO are lacking.^3,6 However, up to 78% of IBS cases are thought to be SIBO,^7-9 which may explain why many SIBO patients find relief with this diet. An LFD does correlate with lower levels of hydrogen on breath testing in IBS patients.¹⁰

The IBS guidelines seem contradictory, though—on the one hand, LFDs are effective and recommended. On the other hand, soluble fiber and prebiotics are also recommended.^11-13 A high soluble fiber diet is associated with improvement in IBS symptoms based on a systematic review and meta-analysis.¹⁴

The LFD can reduce symptoms of IBS and SIBO, but it does not address the underlying root causes. While symptom relief can be helpful, it does not necessarily indicate resolution of the condition. Additionally, many FODMAP foods are important prebiotics, and long-term restriction may negatively affect the gut microbiome. For this reason, the diet is intended as a short-term therapeutic tool rather than a long-term solution.

Even the creators of the LFD at Monash University insist that the diet was designed to be followed for 2-6 weeks until symptoms resolve, followed by reintroduction of FODMAP foods.¹⁵ However, many patients continue on an LFD long-term for fear of symptoms returning. If symptoms return with FODMAP introduction, it likely means that the underlying SIBO or IBS causes have not yet been addressed.

An LFD may negatively impact gut microbiome composition and worsen existing dysbiosis in SIBO patients.¹⁶ It can lead to decreases in key beneficial species such as Akkermansia muciniphila and Bifidobacterium species, which are popular probiotics, Faecalibacterium prausnitzii, an anti-inflammatory, butyrate-producing bacterium, and several others.^17-20 This diet may also increase the prevalence of Bilophila wadsworthia, a hydrogen-sulfide-producing species, associated with inflammation.²⁰

Considering the impact on the microbiome, the question remains whether the LFD is the best approach. One article states that, “In SIBO, the treatment priority, apart from addressing risk factors and identifying the underlying cause, should be striving for the state of eubiosis, characterized by the balance of microbiota colonization. Hence, it remains uncertain whether a low-FODMAP diet is helpful or necessary for patients with SIBO, especially for prolonged periods of time.”¹⁶

Treatment should be corrective of dysbiosis, rather than exacerbating it. A small pilot study showed that switching from a high-fiber diet to a low-fiber, high-simple sugar diet triggered IBS symptoms, decreased small intestinal microbial diversity, and increased small intestinal permeability.²¹ While the LFD is not inherently a low-fiber, high-simple sugar diet, it does restrict many high-fiber foods, limiting healthy fibers that support microbiome health.

Support for Prebiotic and Fiber Intake in SIBO

Studies on IBS patients demonstrate the benefits of soluble fiber on microbiota composition as well as symptoms; however, studies on fiber as an intervention in SIBO patients are limited.¹⁶ Because of the overlap of symptoms between SIBO and IBS, and the fact that many IBS cases are likely SIBO, fiber may also benefit SIBO patients. Well-designed studies on prebiotics and fiber in SIBO treatment are sparse and therefore typically not included in SIBO protocols.

A randomized trial on 77 SIBO patients showed that the combination of 1200 mg rifaximin with 5 g partially hydrolyzed guar gum (PHGG) for 10 days was more useful in eradicating SIBO compared to rifaximin alone. SIBO eradication was 62.1% in the rifaximin group and 87.1% in the rifaximin-plus-PHGG group. Symptom improvement was similar between the two groups. In addition to acting as a prebiotic to balance microbiome health, PHGG also improves intestinal motility, a common problem in SIBO.²²

In pregnancy, certain antibiotics and herbal treatments may be contraindicated, warranting the need for safer and effective treatments for SIBO. Studies on hypothyroid pregnant women with SIBO included a probiotic and prebiotic treatment for 21 days. The supplement included 3 daily doses of probiotics Bifidobacterium infantis, Lactobacillus acidophilus, Enterococcus faecalis, and Bacillus cereus, and prebiotics inulin, cellulose, and oat fiber. Following treatment, breath methane levels and symptoms were decreased in the intervention group. One study showed 46.4% of SIBO-positive pregnant women turned negative. Serum TSH was also decreased, suggesting improved levothyroxine absorption, which is absorbed mainly in the small intestine.^23,24

Won’t Prebiotics Worsen SIBO Symptoms?

Since prebiotics and fiber feed bacteria, there is a question about exacerbating the overgrowth and symptoms. Most clinicians and patients are reluctant to try a therapy that will make them feel worse, even though it’s good for their microbiome. Some studies show that if patients can push past the initial exacerbation, they might experience relief as the microbiota adapts.²⁵

A proof-of-concept study looked at the effects of a prebiotic supplement (beta-galactooligosaccharide [B-GOS]) on 20 healthy individuals for 3 weeks. Initially, flatulence increased significantly but returned to baseline by the end of the 3 weeks. The abundance of butyrate-producing bacteria correlated inversely with the volume of gas. Some species, instead of producing gas when fermenting sugars, produce beneficial SCFAs. This study shows that the functional adaptation of the microbiota to the prebiotic produces less gas and associated issues.²⁶ Another study conducted by the same group showed a shift in the microbiota metabolism toward low-gas-producing pathways and an increase in gas-consuming activity.²⁷ In particular, Bifidobacterium species are non-gas-producing.²⁵

A randomized, double-blind study on 44 patients with functional GI disorders compared the effects of B-GOS versus a low FODMAP diet. After 4 weeks, both groups had statistically significant improvement in symptom scores, although the prebiotic group did not have significant reductions in flatulence and borborygmi. A decrease in symptoms persisted for 2 weeks after discontinuing the prebiotics but reappeared immediately after discontinuing the low FODMAP diet. The microbiota was negatively impacted by the low FODMAP diet and beneficially impacted with prebiotics. The authors concluded that intermittent prebiotic administration might be an alternative to continuous dietary restrictions.²⁰

Flavonoids are non-fiber prebiotics that may be less likely to produce symptoms in SIBO patients. There are no studies in SIBO patients, but smaller clinical studies and animal studies show beneficial changes in the gut microbiota with pomegranate extract supplementation.^28,29

Can Prebiotics Be Used Alongside a Low-FODMAP Diet?

B-GOS was used in conjunction with an LFD in a randomized, placebo-controlled trial of 69 patients with IBS. After 4 weeks, symptom relief was highest in the LFD/B-GOS group compared to the control group. Bifidobacterium and butyrate levels were lower in the LFD and LFD/B-GOS groups compared to the control group.³⁰ This study shows that even with the addition of a prebiotic, the LFD negatively impacts microbiome health.

Another smaller, randomized, placebo-controlled study used fructooligosaccharides (FOS) as a prebiotic along with the LFD. Twenty patients with IBS followed an LFD for 9 weeks. After 3 weeks, participants received either FOS or a placebo for 10 days. Significantly more participants experienced symptom relief with placebo (80%) compared to FOS (30%). However, FOS increased levels of beneficial bacteria compared to placebo.¹⁹ This study shows the importance of prebiotics in microbiome health, but certain prebiotics may exacerbate symptoms.

Practical Takeaways for Helping SIBO Patients Tolerate Fiber/Prebiotics

There are currently no standardized protocols regarding the optimal timing of prebiotic administration or the most effective types of prebiotics for SIBO. Based on the available evidence, a treatment approach that combines antimicrobials with prebiotics, and potentially probiotics, may be preferable for reducing bacterial overgrowth while maintaining microbiome balance. By contrast, antimicrobial therapy paired with a low-FODMAP diet may alleviate symptoms but could compromise intestinal microbiome health.

Several prebiotic intervention studies suggest that patients may experience an initial exacerbation of symptoms, which tends to resolve as the microbiome adapts to the dietary changes. When clinicians set this expectation early in the treatment process, the intervention is less likely to be perceived as unsuccessful, and patients may be more inclined to adhere to the protocol. Implementing concurrent strategies to mitigate symptoms may further support tolerance and compliance.

Strategies for Prebiotic/Fiber Introduction

• Start slow/low with fiber introduction and gradually increase over time.
• Consider broad-spectrum digestive enzymes with meals to reduce gas, bloating, and abdominal distension.³¹ Certain products contain enzymes that help break down plant fibers. One study showed a clinical reduction in IBS symptoms when taking the enzyme alpha-galactosidase with high GOS foods.³²
• Proper food preparation reduces FODMAPs. Soaking dried beans overnight reduces the oligosaccharides that cause gas. Rinse canned beans first; the slimy liquid contains fermentable sugars. Sprouting legumes is another useful method.^33,34
• Taking 4-hour breaks between meals, no snacking, and fasting overnight helps activate the migrating motor complex (MMC).³⁵ The MMC helps cleanse the small intestine of excess bacteria and only operates in a fasted state.¹⁶
• Mindful eating by chewing thoroughly and slowly (to reduce air intake) can help reduce symptoms of gas and bloating. Interestingly, a 4-week study comparing a low-FODMAP diet to a diet that focused on how and when to eat, rather than what foods to eat, showed a similar decrease in IBS symptoms.³⁶
• Prebiotic supplements like PHGG or flavonoids may be better tolerated compared to other prebiotics.²²
• Cooked fruits and vegetables may be easier to tolerate than raw.
• A food journal may help patients better understand their triggers, versus the restrictive elimination of all high-FODMAP foods. Diets should be individualized.
• Dietary fiber variety promotes microbial diversity, which is associated with better health outcomes.^37,38 Restrictive diets may reduce microbiome diversity. Supplement companies offer fiber blends versus single fiber supplements to encourage diversity.

References:

1. Skrzydło-Radomańska B, Cukrowska B. How to Recognize and Treat Small Intestinal Bacterial Overgrowth? Journal of clinical medicine. 2022;11(20).
2. Lauritano EC, Gabrielli M, Scarpellini E, et al. Small intestinal bacterial overgrowth recurrence after antibiotic therapy. Official journal of the American College of Gastroenterology| ACG. 2008;103(8):2031-2035.
3. Redondo-Cuevas L, Belloch L, Martín-Carbonell V, et al. Do Herbal Supplements and Probiotics Complement Antibiotics and Diet in the Management of SIBO? A Randomized Clinical Trial. Nutrients. 2024;16(7).
4. Gibson PR. History of the low FODMAP diet. Journal of gastroenterology and hepatology. 2017;32 Suppl 1:5-7.
5. Siebecker A. SIBO Diet. SIBO INFO 2025; https://www.siboinfo.com/sibo-diet.html, Accessed Jan 2026.
6. Souza C, Rocha R, Cotrim HP. Diet and intestinal bacterial overgrowth: Is there evidence? World journal of clinical cases. 2022;10(15):4713-4716.
7. Pyleris E, Giamarellos-Bourboulis EJ, Tzivras D, Koussoulas V, Barbatzas C, Pimentel M. The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome. Digestive diseases and sciences. 2012;57(5):1321-1329.
8. Ding XW, Liu YX, Fang XC, Liu K, Wei YY, Shan MH. The relationship between small intestinal bacterial overgrowth and irritable bowel syndrome. European review for medical and pharmacological sciences. 2017;21(22):5191-5196.
9. Ghoshal UC, Srivastava D. Irritable bowel syndrome and small intestinal bacterial overgrowth: meaningful association or unnecessary hype. World journal of gastroenterology : WJG. 2014;20(10):2482-2491.
10. McIntosh K, Reed DE, Schneider T, et al. FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial. Gut. 2017;66(7):1241-1251.
11. Vasant DH, Paine PA, Black CJ, et al. British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut. 2021;70(7):1214-1240.
12. Bonetto S, Fagoonee S, Battaglia E, Grassini M, Saracco GM, Pellicano R. Recent advances in the treatment of irritable bowel syndrome. Pol Arch Intern Med. 2021;131(7-8):709-715.
13. Lacy BE, Pimentel M, Brenner DM, et al. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. The American journal of gastroenterology. 2021;116(1):17-44.
14. Moayyedi P, Quigley EM, Lacy BE, et al. The effect of fiber supplementation on irritable bowel syndrome: a systematic review and meta-analysis. The American journal of gastroenterology. 2014;109(9):1367-1374.
15. Barrett J. Just 2-6 weeks, not a STRICT diet for life. FODMAP Blog 2015; https://www.monashfodmap.com/blog/just-2-6-weeks-it-is-not-diet-for-life_8/, Accessed Jan 2026.
16. Wielgosz-Grochowska JP, Domanski N, Drywień ME. Efficacy of an Irritable Bowel Syndrome Diet in the Treatment of Small Intestinal Bacterial Overgrowth: A Narrative Review. Nutrients. 2022;14(16).
17. Halmos EP, Christophersen CT, Bird AR, Shepherd SJ, Gibson PR, Muir JG. Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut. 2015;64(1):93-100.
18. Cox SR, Lindsay JO, Fromentin S, et al. Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial. Gastroenterology. 2020;158(1):176-188.e177.
19. Hustoft TN, Hausken T, Ystad SO, et al. Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society. 2017;29(4).
20. Huaman JW, Mego M, Manichanh C, et al. Effects of Prebiotics vs a Diet Low in FODMAPs in Patients With Functional Gut Disorders. Gastroenterology. 2018;155(4):1004-1007.
21. Saffouri GB, Shields-Cutler RR, Chen J, et al. Small intestinal microbial dysbiosis underlies symptoms associated with functional gastrointestinal disorders. Nature communications. 2019;10(1):2012.
22. Furnari M, Parodi A, Gemignani L, et al. Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth. Alimentary pharmacology & therapeutics. 2010;32(8):1000-1006.
23. Ouyang Q, Xu Y, Ban Y, et al. Probiotics and Prebiotics in Subclinical Hypothyroidism of Pregnancy with Small Intestinal Bacterial Overgrowth. Probiotics and antimicrobial proteins. 2024;16(2):579-588.
24. Hao Y, Xu Y, Ban Y, et al. Efficacy evaluation of probiotics combined with prebiotics in patients with clinical hypothyroidism complicated with small intestinal bacterial overgrowth during the second trimester of pregnancy. Frontiers in cellular and infection microbiology. 2022;12:983027.
25. Deehan EC, Zhang Z, Nguyen NK, et al. Adaptation to tolerate high doses of arabinoxylan is associated with fecal levels of Bifidobacterium longum. Gut Microbes. 2024;16(1):2363021.
26. Mego M, Manichanh C, Accarino A, et al. Metabolic adaptation of colonic microbiota to galactooligosaccharides: a proof-of-concept-study. Alimentary pharmacology & therapeutics. 2017;45(5):670-680.
27. Mego M, Accarino A, Tzortzis G, et al. Colonic gas homeostasis: Mechanisms of adaptation following HOST-G904 galactooligosaccharide use in humans. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society. 2017;29(9).
28. Maphetu N, Unuofin JO, Masuku NP, Olisah C, Lebelo SL. Medicinal uses, pharmacological activities, phytochemistry, and the molecular mechanisms of Punica granatum L. (pomegranate) plant extracts: A review. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2022;153:113256.
29. Li Z, Henning SM, Lee RP, et al. Pomegranate extract induces ellagitannin metabolite formation and changes stool microbiota in healthy volunteers. Food & function. 2015;6(8):2487-2495.
30. Wilson B, Rossi M, Kanno T, et al. β-Galactooligosaccharide in Conjunction With Low FODMAP Diet Improves Irritable Bowel Syndrome Symptoms but Reduces Fecal Bifidobacteria. The American journal of gastroenterology. 2020;115(6):906-915.
31. Martin-Biggers J. A multi-digestive enzyme and herbal dietary supplement reduces bloating in a single use in healthy adults: A randomized, placebo-controlled, cross over study. Nutrition and Dietary Supplements. 2024:51-57.
32. Tuck CJ, Taylor KM, Gibson PR, Barrett JS, Muir JG. Increasing Symptoms in Irritable Bowel Symptoms With Ingestion of Galacto-Oligosaccharides Are Mitigated by α-Galactosidase Treatment. The American journal of gastroenterology. 2018;113(1):124-134.
33. Ranganathan S. Evaluation of two methods to reduce legume-related flatulence through enzymatic digestion of flatulence factors, Hochschule Rhein-Waal; 2020.
34. AH Sorour M, A Fahmy H. EFFECT OF SOAKING, GERMINATION AND MICROWAVE COOKING ON FLATULENCE-CAUSING OLIGOSACCHARIDES OF CERTAIN LEGUMES. Assiut Journal of Agricultural Sciences. 2007;38(3):37-48.
35. Sandberg-Lewis SS, A. SIBO: Dysbiosis Has A New Name. Townsend Letter. 2015(Feb/March 2015).
36. Böhn L, Störsrud S, Liljebo T, et al. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. Gastroenterology. 2015;149(6):1399-1407.e1392.
37. Huang X, Gao Y, Chen W, et al. Dietary variety relates to gut microbiota diversity and abundance in humans. European journal of nutrition. 2022;61(8):3915-3928.
38. Singh R, McDonald D, Hernandez AR, et al. Temporal nutrition analysis associates dietary regularity and quality with gut microbiome diversity: insights from the Food & You digital cohort. Nature communications. 2025;16(1):8635.